UPDATE: JPMorgan Starts CytomX Therapeutics (CTMX) at Overweight
Tweet Send to a Friend
(Updated - March 29, 2021 5:05 AM EDT)
JPMorgan analyst Anupam Rama initiates coverage on CytomX Therapeutics (NASDAQ: CTMX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Anupam Rama initiates coverage on CytomX Therapeutics (NASDAQ: CTMX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
